The global spine biologics market will likely grow at a compound annual growth rate of 4.5 percent between 2018 and 2023, based on a Market.biz report, according to Business News.
Here are three observations.
1. In 2017, the market was worth $2.1 billion.
2. The spinal biologics market is anticipated to hit $2.74 billion by 2023.
3. Key market players include NuVasive, X-Spine Systems, Medtronic, Exactech, Arthrex, Zimmer Biomet, Stryker, Orthofix, Wright Medical Technology, DR PRP USA, Nutech, K2M and DePuy Synthes.